Given the critical function of RNR in cancer cells, it is clear that RNR has long been recognized as a promising target for treating cancer11,19 and several compounds, such as radical scavengers, iron chelators, and nucleoside analogs, have been developed as RNR inhibitors in the anti-cancer compounds field. This evidence concerns the gene NR2E3 and cancer.